Health and Wellness
The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders.
The model also calculates biological ageing and survival patterns to support personalized health risk management.
Also, South Korea has piloted a social media app-based counselling service for reclusive teens.
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.
Founded by a former financial analyst, Sol aims to close research and care gaps for Asian women navigating menopause and midlife.
The partnership allows Sleep Cycle users to access Dreem Health’s network of sleep specialists for evaluation and treatment of sleep disorders directly through the app.
The company says it is seeing an increased demand for testosterone hormone treatment.
Calm users identified as needing high-acuity mental healthcare will be connected with LifeStance’s virtual behavioral health specialists.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
VUNO, Kakao Healthcare, Skylabs, and Remidio advance into Europe with partnership deals and regulatory approvals for AI in cardiac, chronic, and eye care.